Adweek: Excedrin Won the Debate on Twitter Before It Even Started by Curing Your #DebateHeadache

Excedrin, the pain reliever, decided to use humor to newsjack the final presidential debate yesterday. According to a recent Adweek article, the company generated a 3,100 percent lift in chatter on Twitter with the promoted trend ad stating how the possibility of a debate headache was high and providing Americans with a solution.

Marketers for the brand continued to share six more tweets with #DebateHeadache to continue the momentum. The brand’s account received 46,000 Twitter mentions yesterday, a 360 percent increase from the first three days of the week, according to Talkwalker.

Excedrin’s additional tweets included messaging announcing research with the number of Americans who will have an election headache and how to relieve it. Users responded giving props to the company for successfully inserting themselves into the conversation in an entertaining way.